We’re part of the revolution in Parkinson’s research!
Join Us as we invest in this MIT Research!
A Dream Team of Researchers at MIT is taking on Parkinson’s and we’re supporting them!
The team includes MIT’s Dr. Robert Langer. In December 2018, two decades of research starting in the Langer Lab at MIT resulted in FDA approval of Inbrija, the first approved inhaled levodopa powder for Parkinson’s patients.
We're supporting a revolution in Parkinson's research at MIT! #curenowpd #weareonevoice #unity #nosilos
Let's Get Started!!